background: Several protocols for the isolation of luteinized granulosa cells (LGCs) contained in follicular fluid have been described but no previously published study has compared the relative efficiency of these protocols. Our objective is to obtain conclusive scientific evidence for the superiority of one method over another.
Introduction
Granulosa cells (GCs) are somatic cells that exist within the developing oocyte in the ovarian follicle (Brůčková et al., 2008) and form a multilayer that surrounds the oocyte. The functions of GCs include the production of a myriad of growth factors that are vital for oocyte development, and of sex steroids, which regulate ovarian function.
Following ovulation, GCs are luteinized and produce progesterone in order to maintain the viability of the endometrium during a potential pregnancy (Perry et al., 2005) . Given the importance of luteinized GCs (LGCs) to the development of the oocyte and the maintenance of pregnancy, they are often used as a model for studying multiple aspects of ovarian function. Moreover, LGCs are identified as a valuable tool for studies in reproductive biology, given the ease of access during assisted reproduction techniques (Greenseid et al., 2011) .
Human primary LGCs employed for in vitro studies are obtained during oocyte retrieval from woman undergoing controlled ovarian stimulation (COS) protocols. The oocytes are collected by an invasive method employing transvaginal ultrasound-guided aspiration, which requires penetration of the uterine wall, ovarian membranes and connective tissue. Given that these structures are vascularized, the cells obtained from the follicular fluid are contaminated with vascular components (Levay et al., 1997; Jozwik and Wolczynski, 1998) , thus resulting in a heterogeneous cell population in which LGCs are mixed with leukocytes (15 -17%; Beckmann et al., 1991; Figenschau et al., 1997) and erythrocytes as well as other cell types, such as endothelial and epithelial cells.
The presence of immune cells in the follicular fluid is especially critical, as these directly influence LGC function. Indeed, the results of molecular and cell culture studies (Quinn et al., 2006) of follicular aspirates in which LGCs have not been purified must be interpreted with caution. Isolation techniques are necessary to establish a pure, or almost pure, in vitro culture of LGCs if we want to determine the specific role of these cells in follicle development and ovarian function.
The gold standard method for isolation of pure cell populations is considered to be fluorescence-activated cell sorting (FACS), a specialized method of flow cytometry by which cell populations expressing a specific marker on the cell surface are selected. However, to our knowledge, no previous report has described a single marker, or combination of multiple membrane markers, that are positively expressed in LGCs, although there have been descriptions of said markers in contaminating cells found in the follicular fluid, such as cells deriving from the myeloid lineage, allowing a positive discrimination of these cells.
Sorting methods for isolating LGCs and purifying this specific cell type are based on the negative selection of LGCs through the depletion of contaminating immune cells.
Currently, employed strategies for the depletion of unwanted cells can be classified in two main groups, according to a criterion of restrictiveness: (i) highly specific strategies of depletion based on immunological recognition of specific cell markers of contaminating cells (Neurauter et al., 2007) and (ii) non-specific strategies of depletion based on the differential physical properties of contaminating cells and desired cells.
(i) The methods based on the recognition of specific cell markers in contaminating immune cells are expected to be more restrictive and thus render LGCs of purity .90%. However, the number of LGCs lost during the application of these methods is usually very high, which rules out their subsequent use for the purpose of in vitro culture. (ii) On the other hand, methods based on the differential physical properties of contaminating immune cells and LGCs should lead to a greater number of LGCs being obtained than with the above method. However, because of the less restrictive nature of this isolation process, a higher percentage of immune cells will probably 'contaminate' the resulting cell suspension.
Our objective in this work was to compare the efficiency of the depletion methods described for the isolation of LGCs and determine which of them allows the highest number of LGCs to be obtained for culture without compromising their purity. For this purpose, we estimated the percentage of LGCs recovered, evaluated the purity of the cell suspension obtained and established the rate of total cell viability after LGC isolation using the six isolation protocols described below.
Materials and Methods

Collection of LGCs
In order to isolate LGCs, the follicular fluid was collected via transvaginal ultrasound-guided aspiration in egg donors (n ¼ 72) undergoing a 'classic' protocol of COS (Fedorcsak et al., 2004) in our institution (patient characteristics in Table I ). The COS protocol consisted of pituitary downregulation with an GnRH agonist, ovarian stimulation with recombinant FSH and ovulation induction with hCG. Women gave their written informed consent, and the study protocol was approved by the institutional ethical committee (CEIC-IVI Valencia).
Experimental design
Each of the LGCs purification methods evaluated in this study was repeated six times. As some of the methods are subject to the skills, and selection and evaluation criteria of the person manipulating the samples, three individuals performed each of the purification methods twice.
LGCs were collected and two samples were pooled, therefore six samples were used for each of the purification methods. The efficiency of each method was evaluated by pooling and separating the follicular fluid into two aliquots named 'C' (control) and 'E' (experimental). The 'C' aliquot was used as an internal standard control against which the 'E' aliquots were compared, after a specific isolation method was completed. Follicular fluid-derived cells in the 'C' aliquots were separated from erythrocytes by density gradient centrifugation (Kossowska et al., 2009 ) on 5 ml of Ficoll (v/v, Sigma-Aldrich, St. Louis, USA) for 20 min at 400g. Following centrifugation, three layers could be distinguished: a top layer containing the follicular fluid, a bottom layer containing erythrocytes and, in the middle, a ring-like layer containing the cells-derived from the follicular fluid. This middle layer was collected, washed by centrifugation for 5 min at 600g and resuspended in 1-ml phosphate-buffered saline (PBS) with 1% bovine serum albumin (BSA).
In order to break up aggregates mechanically, Pasteur pipettes were heated and stretched to obtain different diameters, and these were used sequentially, from wide to narrower bore, to disperse the follicular fluid-derived cells. In order to reduce aggregate size homogeneously during the whole study, we took special care in maintaining pipette diameter uniformity between groups (Figs 1 -3) .
'E' aliquots were processed in the following.
(i) For assessment of the methods based on recognition of specific cell markers, such as FACS, Dynabeads and MACS (magnetic-activated cell sorting; Fig. 1 ), 'E' aliquots were first processed in exactly the same way as 'C' aliquots. Subsequently, they were subjected to the isolation methods in question and the recovered cells were resuspended in 1-ml PBS with BSA 1%. (ii) For assessment of the methods that are based on the physical properties of LGCs and adhesion properties of immune cells (with the exception of the methodology employing cell strainers, which required a unique pre-isolation protocol, described below) erythrocytes were depleted from 'E' aliquots by means of density gradient centrifugation before performing the isolation method to be assayed (cell aggregates and Flask; Fig. 2 ). After the isolation methods, the LGCs were washed, resuspended in 1-ml PBS with 1% BSA and mechanically dispersed using pipettes stretched to different diameters.
(iii) In 'E' aliquots which were designated to be processed by the cell strainer (filter) method (Fig. 3 ), erythrocytes were not first depleted by density gradient. Instead, 'E' aliquots were passed directly through cell strainers following the procedures for the isolation of LGCs described below. The obtained cell suspension was washed, resuspended in 1-ml PBS with 1% BSA and mechanically dispersed.
Isolation methods tested
The FACS method
The FACS method (Neubourg et al., 1996; Evagelatou et al., 1997) , described in countless works, is a method for sorting a heterogeneous mixture of cells into two or more containers, one cell at a time, and is based upon the specific light scattering and fluorescent characteristics of each type cell. In order to isolate
LGCs by means of FACS, cells obtained from the follicular fluid were selected against CD45, a common marker of cells deriving from the myeloid lineage, thereby allowing the depletion of immune cells in a suspension. To do this, the monoclonal mouse anti-human CD45 antibody (Sigma-Aldrich) was added to the cell suspension (diluted 1:20 in PBS) for 30 min at room temperature. Following incubation, the primary antibody was eliminated by centrifugation for 5 min at 600g and the pellet was then resuspended in PBS. This cell suspension was incubated on ice for 1 h in the dark with a secondary goat anti-mouse immunoglobulin (Ig)G antibody-labelled with fluorescein isothiocyanate (FITC; Anti-Mouse IgG-FITC antibody, Sigma-Aldrich) at a dilution of 1:100. Finally, LGCs were washed as described previously, resuspended in a volume of 500 ml PBS and exposed to 5-mg/ml propidium iodide (PI; Sigma-Aldrich) to exclude cells damaged during the process, which were separated with a FACS calibur instrument (Beckman Coulter, Brea, CA, USA) and CellQuest software (Beckman Coulter). Figure 1 Experimental design for the evaluation of the efficiency of the methods based on the recognition of specific cell markers in the isolation of LGC.
Dynabeads method
As described previously (Smith et al., 1997; Enien et al., 1998; Salmassi et al., 2005; Bencomo et al., 2006; Acosta et al., 2009) , including one report by our own group (Garrido et al., 2002) , the Dynabeads methodology has been used for the isolation of LGCs, and is based on the depletion of unwanted cells using magnetic beads covalently bound to antibodies that recognize specific markers present on the cell surface. We employed this technology to deplete immune cells by incubating samples with a monoclonal mouse anti-human CD45 antibody (CD45 clone BRA-55, Sigma-Aldrich) diluted 1:20 in PBS, for 30 min at room temperature. Following incubation, the excess primary antibody was eliminated through centrifugation (5 min, 600g). The cell pellet was subsequently resuspended and incubated with magnetic beads coated with secondary antibody (Dynabeads pan mouse IgG, Dilution: 1:20; Invitrogen, Carlsbad, CA, USA) for 30 min at 48C while being agitated at 160 g. The plastic tube containing the mixture was then placed next to a fixed magnet for 2 min. The unlabelled cells of interest were collected by decanting while the immune cells associated with the beads remained attracted and retained to the plastic wall closest to the magnet.
MACS method
MACS method (Miltenyi Biotec, Germany), previously described by other authors (Pesce and De Felici, 1995; Kodaman and Behrman, 2001) . In a similar fashion to Dynabeads, the MACs methodology is based on the depletion of unwanted cells using magnetic forces. The main differences between the two technologies are the smaller size of the MACS microbeads employed for separation and the fact that in the MACS procedure the magnetic separation is performed in a column filled with magnetic beads rather than using a classic magnet.
Following the manufacture's recommendations, cells obtained after mechanical cell dispersion were washed and resuspended in 80 ml of MACS buffer (Miltenyi Biotec S.L., Germany), to which 20 ml of CD45 monoclonal antibody covalently bound to magnetic microbeads (CD45 MicroBeads, human; Miltenyi Biotec S.L., Germany) were added. The mixture was incubated for 15 min in a refrigerator (2 -88C), the cell suspension was washed and the pellet was resuspended in 500 ml MACS buffer.
Finally, the cell suspension was passed through the MACS magnetic column, which retained the cells labelled with CD45 microbeads and the unlabelled cells were collected.
Cell aggregation method
LGCs from the follicular fluid form aggregates of a considerably larger size than those formed by immune cells, a characteristic that can be employed to physically isolate this cell type. The follicular fluid-derived cells collected in the middle layer following density gradient were carefully aspirated, transferred into a Petri dish and observed under a dissecting microscope. All structures which, according to the criteria of the observer, showed that ≥20 aggregated cells were collected manually with a Pasteur pipette and subsequently washed and dispersed, as described above (Figenschau et al., 1997) . 
Flask method
This method takes advantage of the fast and selective adherence of leukocytes to the surface of cell culture plastic ware. In order to deplete the immune cells from the cell suspension, follicular fluid-derived cells obtained by the density gradient were collected from the interface, incubated in 20-ml PBS and poured into a T75 Flask (BD Biosciences, Oxford, UK), where they were maintained at 378C for 15 min. It was expected that, while white cells would adhere to the plastic during this period, LGCs would not, thus allowing the easy segregation of the two cell types according to this physical property. To test this possibility, the flask was decanted to recover the non-adhering, putative LGCs (Fedorcsák et al., 2007) .
40-mm-filter method
The cell strainer methodology is based on the fact that LGCs form large cell aggregates in such a way that clusters can be retained by 40-mm pore cell strainers while erythrocytes and other blood contaminants (such as single cells and aggregates of a smaller size) pass through the strainer.
Following the cell strainer methodology (Carlberg et al., 2000; Richardson et al., 2009 ) but with some modifications (Fig. 3) , the aspirates were first filtered through a 40-mm cell strainer (BD Biosciences) and the hypothetical clusters of LGCs were retained. The strainer was rinsed with 12-ml PBS in order to remove the last traces of blood contaminants and the strainer was then back washed with PBS to collect the 'hypothetical'
LGCs. The acquired suspension was incubated for several minutes and repeatedly aspirated through Pasteur pipettes stretched to different diameters to break up aggregates mechanically. The suspension was then filtered through a 70-mm cell strainer (BD Biosciences) to remove unwanted undispersed material, which was retained in the filter. The cell suspension, collected after filtering the sample, was subsequently washed by centrifugation for 5 min at 600g, after which the supernatant was removed and the pellet was resuspended in 1-ml PBS.
Determination of absolute count, cell viability and percentage of CD45 contaminating cells by flow cytometry
Absolute count by flow cytometry
After assaying each specific isolation method in 'E' aliquots, the total number of cells was determined through cytometric analysis in both 'C' and 'E' aliquots using flow-count fluorospheres (Beckman Coulter) of uniform size and containing a dye with a fluorescent emission range of 525 -700 nm when excited at 488 nm. Following the manufacturer's instructions, 100 ml flow-count fluorospheres (1025 fluorospheres per ml) were added per 100 ml cell suspension and the mix was passed through the cytometer. The total cell number was calculated using the following formula: contaminating CD45 cells in each of the original 1-ml 'C' and 'E' aliquots. In one fraction of each 'C' and 'E' aliquot, an antibody specific for CD45 directly labelled with PE (anti-CD45 phycoerythrin-conjugated; Beckman Coulter) was added at a dilution of 1:10. The other fraction was incubated with a similar concentration of human IgG1 isotype labelled with PE (IgG1-PE, Beckman Coulter) as a negative control for CD45 antibodies, and to establish a baseline for positive CD45 counting. All fractions were subsequently incubated on ice for 1 h in the dark, after which they were centrifuged to remove excess primary unlabelled antibodies. The pellets were finally resuspended in 500-ml PBS, to which 5-mg/ml PI was added (Sigma-Aldrich) with the aim of being able to exclude damaged cells during the cytometric analysis. The total cell viability (PI + cells) of the cell suspension after the purification procedure and the percentage of the CD45+population were determined using Cytomics FC500 (Beckman Coulter), which counted 10 000 events per sample.
Formulas used to determinate the parameters of interest
In order to assess the percentage of LGCs recovered, we first estimated the LGC count in the 'C' and the corresponding 'E' aliquots after each isolation method. To do this, the absolute count after flow cytometry was corrected by subtracting the percentage of contaminating CD45 cells according to the following formula:
Number of LGCs = Absolute count × 100 − percentage of CD45 + cells 100
The percentage of recovered LGCs was subsequently estimated by the formula:
Number of LGCs in aliquot 'E' Number of LGCs in aliquot 'C' × 100
In order to evaluate the efficiency of the depletion of immune cells (percentage reduction in CD45+cells) by each method, the following formula was used:
The percentage cell viability preserved by each method was estimated according to the formula:
Statistical analysis
Data are expressed as mean + SD. As the data were normally distributed, ANOVA test was performed. To adjust for multiple comparisons, post-hoc Bonferroni and Scheffé test were applied. Significance was defined as P , 0.05. Statistical analysis was performed using the Statistical Package for Social Sciences 17.0 (SPSS, Chicago, IL, USA).
Results
Methods based on the recognition of specific cell markers: FACS, Dynabeads and MACS
Flow cytometric analysis in 'C' control aliquots showed that the amount of CD45+contaminating cells pre-purification was quite similar in all groups (ranging from 17.35 to 19.33%). Similarly, a small but slight variation in cell viability (ranging from 98.35 to 96.85%) was observed from group to group. After purification, analysis of the flow cytometry data revealed that the CD45+contaminating cells in 'E' aliquots had been reduced by 90-100% by the depletion techniques, based on the recognition of specific cell markers (Table II) .
As expected, FACS was the most effective of these methods in reducing the immune cell population, with nearly 0.1% of CD45+ contaminating cells detected in the 'E' aliquots. However, the Dynabeads and MACS were also highly efficient in reducing CD45+ contamination, with no significant differences between them.
Despite the high percentage purity of the LGCs obtained, we observed a drastic reduction in the number of LGCs recovered by the MACS, Dynabeads and FACS technologies when compared with the other methods. Indeed, the highest number of unrecovered (lost) LGCs occurred in the Dynabeads method. Although we expected that the FACS technology would give the highest number Results represent flow cytometry analysis, expressed as mean + SD (n ¼ 6, as samples were pooled from two patients). Identical superscripts within the same column denote significant differences (P , 0.05) between the first category and the remaining, from top to bottom. Viability: percentage of total cells which retained viability after performing each purification method. CD45+cells: final concentration of CD45+ contaminating cells after performing the purification method. CD45 reduction: efficiency of each method in depleting (CD45+) contaminating cells.
LGCs recovered: percentage of viable LGCs which could be recovered by each purification method.
of recovered cells, the data obtained in flow cytometric analysis showed that recovery of LGCs barely reached 20%, as almost 50% of cells died during the sorting process. In this way, FACS proved to be a less efficient technology in terms of recovering viable LGCs than the methods based on the differential adhesive/aggregative properties of immune cells.
Methods based on the differential adhesive/ aggregative properties of LGC and immune cells
Cell aggregation and flask methods
In agreement with the similar processing performed in all the 'C' aliquots in all groups, the mean percentage of CD45+ contaminating cells pre-purification in these groups (15.98 + 4.9) was similar to data observed for the above methods based on the recognition of specific cell markers (18.32 + 2.47). Similar slight variations in cell viability (range: 99.65 -97.01%) were observed pre-purification in these groups.
Both the aggregation and Flask methods provided good cell viability and a high percentage (average 65%) of recovered LGCs (Table II) . Indeed, these methodologies gave the highest percentage of recovered
LGCs of all the protocols tested, though it should be pointed out that a high variability in recovered LGCs (aggregation: 73.20 + 6.2; flask: 51.63 + 12.6) was observed among samples. In particular, the aggregation method produced the highest variability, probably because it involved the subjective criteria of the person performing the separation. Aside from the high variability in the results obtained, the main inconvenience of these methodologies seems to be their inability to discriminate between different cell populations. As a result, they were less effective in selectively depleting white cells, as demonstrated by the low percentage reduction in contaminating CD45+cells compared with the other methods.
LGCs isolation involving removal of blood contaminants by a 'cell strainer' (filter) Analysis of viability and CD45 contamination pre-purification showed values of 1.80 + 0.3 and 18.23 + 5.3, respectively, in agreement with all the 'C' aliquots. The cell strainer technology gave a high percentage of recovered LGCs. Flow cytometry revealed that barely 3.29% of the cells in the suspension belonged to the myeloid linage, and an 82% reduction was observed in the percentage of cells labelled with CD45 (Table II) . Overall, filtering was the most efficient method, as it resulted in the highest percentage of recovered LGCs with acceptable levels of CD45 contamination.
Discussion
To our knowledge, this is the first work that compares the efficiency of the most widely employed methods of isolating LGCs in terms of total number, viability of LGCs recovered and percentage of contaminating cells remaining. In terms of contamination, we focused our study only on the number of CD45+ (immune cells), although leukocytes from peripheral blood are the most abundant contaminating population in the follicular fluid, once the erythrocytes have been depleted. We did not evaluate other minor contaminating cell populations from the vascular system, such as endothelial cells or other steroidogenic cells of the follicle wall and ovarian stroma, owing to the low concentration of these components in the follicular fluid (Fedorcsák et al., 2007) . Moreover, because of their high secretory activity, white cells are expected to interfere strongly with the activity/secretion profile of GCs. Our results demonstrate that the isolation of LGCs using magnetic devices is a powerful technique for obtaining a pure and viable population of LGCs. Therefore, these technologies should be the method of choice when a study uses a technique such as quantitative fluorescence PCR, differential display or array analysis, which is not limited by the amount of biological material available but which does require pure, uncontaminated samples if the results obtained are to be considered reliable. However, such techniques would not seem to be appropriate for studies designed to include diverse in vitro assays involving LGCs. The reason for this is that LGCs are terminal cells, and the primary culture of this cell type produces a very slow rate of replication, or none. Therefore, the hypothetical number of in vitro assays that can be performed will be limited by the amount of biological material initially available. This obstacle is especially critical if pools of LGCs cannot be employed, in order to preserve the individual characteristics of each patient sample. Based on our results, the most appropriate technique in such a scenario would be the strainfilter method, which provides higher number of LGCs with acceptable levels of purity, without compromising the viability of cells in subsequent culture. In fact the present study has arisen as a consequence of attempts in our laboratory to implement a more efficient LGCs isolation protocol than the Dynabeads methodology we have used in the past, with the aim of ensuring a sufficient number of LGCs with which to perform the in vitro culture assays required for our objectives (Gómez et al., 2011) . Before carrying out the experiments described herein, we reviewed the literature in order to study the different isolation methods currently available and to identify which of them were most commonly used by researchers. Surprisingly, after reproducing the methods in our laboratory, we have found that FACS, the gold standard technique for isolation of pure cell populations, is not as efficient as we expected. Despite providing the highest percentage of pure LGCs, FACS led to a low viability rate during the process, which suggests that LGCs are very sensitive to cell sorting. As a consequence, at least in our hands, FACS resulted in a lower number of recovered LGCs than the other methods and, therefore, would not appear to be an appropriate technique for the isolation of LGCs prior to in vitro culture. The methodologies based on the magnetic separation of LGCs provided acceptable levels of purity. Thus, pragmatism is likely to tip the balance in favour of selecting magnetic methods over FACS when purity of the cell population is the main criterion. The flask and aggregation methods seem to be the least appropriate methods for isolating LGCs, principally because of the high numbers of contaminating immune cells present following isolation. We cannot envisage a scenario in which flask or aggregation methods might provide advantages over magnetic or cell strainer methods when LGCs are subsequently to be employed in the context of molecular biology or in vitro culture. Naturally, groups that employ the individual methods assayed herein routinely, specifically those involving flask or aggregated methodology, must generally obtain more efficient results than those we report here. However, we believe the present work can serve as a useful guide for newcomers who have never isolated LGCs and who wish to choose the methodology which best fits the individual aims and characteristics of their research projects. We also believe that more experienced researchers in the field might benefit from our data by improving the methodology they currently use or by adopting a new approach which overcomes the obstacles and inconveniences they may experience during the isolation of LGCs.
In summary, after assaying the most commonly used methods of LGC isolation, we conclude that FACS is the best protocol for isolating
LGCs when purity is the principal criterion. Magnetic separation is the best option when both purity and viability are essential for subsequent experimentation. However, cell straining is probably the least laborious, most pragmatic and, when considered in global terms, most efficient technology with which to isolate LGCs, as it offers the best combination of purity, viability and total number of cells recovered from all the methodologies currently available.
